Option chain shows key data for Xenetic Biosciences's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Xenetic Biosciences.

Xenetic Biosciences (NASDAQ:XBIO) Stock, Option Chain

XENETIC BIOSCIENCES INC

Xenetic Biosciences

Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors.

Earnings

Earnings Misses

News

Penny Stocks

Markets

Trading Ideas

AFMD

XBIO

Xenetic Biosciences (NASDAQ: XBIO) came out with a quarterly loss of $0.78 per share versus the Zacks Consensus Estimate of a loss of $0.79. This compares to loss of $0.60 per share a year ago. These figures are adjusted for non-recurring items.

Xenetic Biosciences Reports Q1 Loss, Misses Revenue Estimates

Analyst Color

Biotech

Downgrades

Health Care

Analyst Ratings

General

Lack Of Catalysts Prompts Analyst To Downgrade Xenetic Biosciences

Small Cap

Intraday Update

Movers

ACHR

ALGS

ANTE

ATNX

AUTL

BBLN

BLBD

CRVS

DBVT

DRMA

DRTT

EAST

EFSH

GLDD

GLMD

HCDI

IBRX

IMPL

JAGX

JWAC

LMFA

Larimar Therapeutics, Inc. - Common Stock

LRMR

MGOL

MIND

MNDY

NGMS

NSPR

OCUP

ORMP

OSUR

PRSO

SANA

SBFM

SRPT

SWIM

THCH

TIVC

TTCF

TWST

VERO

WISA

WLDS

XELA

ZAPP

ZKIN

Gainers


	NeoGames S.A. (NASDAQ: NGMS) shares climbed 113.3% to $27.38 as the company agreed to be acquired by Aristocrat Leisure Limited for $29.50 per share in cash.


Why Venus Concept Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Monday&#39;s Mid-Day Session

Xenetic Biosciences Inc

Xenetic Biosciences Inc Warrants (19/07/2024)

XBiotech Inc

Press Releases

Xenetic Biosciences, Inc. Reports Third Quarter 2024 Financial Results

Xenetic Biosciences, Inc. Presents Positive Preclinical Data Highlighting the Potential of Co-Administration of DNase I with CAR T Cells in a Murine Model of Melanoma Lung Metastasis

Xenetic Biosciences, Inc. Releases Virtual Investor "What This Means" Segment

Xenetic Biosciences, Inc. Enters into Clinical Trial Services Agreement with PeriNess Ltd. to Accelerate Development of DNase I Oncology Program

Xenetic Biosciences, Inc. Extends Research Agreement with the University of Virginia for the Advancement of its DNase-Based Oncology Platform

Xenetic Biosciences, Inc. Announces Abstract Accepted for Poster Presentation at the Society for Immunotherapy of Cancer (SITC) Spring Scientific 2025 Cell Therapy Meeting

Xenetic Biosciences, Inc. Presents Positive Preclinical Data Underscoring the Potential of DNase I as an Adjunctive Treatment to Enhance Immunotherapeutic Responses

Xenetic Biosciences, Inc. Reports Full Year 2024 Financial Results

Xenetic Biosciences, Inc. Announces Entry by Collaboration Partner into a Clinical Study Agreement to Advance Development of DNase Platform for the Treatment of Relapsed/Refractory Osteosarcoma and Ewing Sarcoma

Aditxt

Allarity Therapeutics, Inc. - Common stock

Allarity Therapeutics

Aptorum Group Limited - Class A Ordinary Shares

Aptorum Gr

Azitra

bioAffinity Technologies, Inc. - Common Stock

bioAffinity Technologies

Creative Medical Technology Holdings, Inc. - Common Stock

Creative Medical Tech

Cyclacel Pharmaceuticals, Inc. - Common Stock

Cyclacel Pharmaceuticals

Ensysce Biosciences

Galecto

GT Biopharma

Kazia Therapeutics Limited - American Depositary Shares

Kazia Therapeutics

Mustang Bio

NuCana

Oragenics

Organovo Holdings

Phio Pharmaceuticals Corp. - Common Stock

Phio Pharma

Quoin Pharmaceuticals, Ltd. - American Depositary Shares

Quoin Pharmaceuticals

Sunshine Biopharma

SILO Pharma

Soligenix

Synaptogenix

Sonnet BioTherapeutics Holdings, Inc. - Common Stock

Sonnet BioTherapeutics

Theriva Biologics

Longevity Health Holdings, Inc. - Common Stock

Longevity Health Holdings

XTL Biopharmaceuticals Ltd. - American Depositary Shares

XTL Biopharmaceuticals

Comments

Xenetic Biosciences

Xenetic Biosciences (XBIO) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga